Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child.
Jolien J M FreriksenMinou van SeyenAli JuddDiana M GibbIntira Jeannie CollinsRick GreupinkFrans G M RusselJoost Paulus Hubertus DrenthAngela ColbersDavid Marinus BurgerPublished in: Alimentary pharmacology & therapeutics (2019)
Treatment of HCV infection during pregnancy is realistic, as DAAs are highly effective and treatment duration is relatively short. There is an urgent need to study DAAs during pregnancy and lactation to contribute to the goal of HCV elimination.